What is the effect of ACE inhibitors or ARBs on diabetic nephropathy?

Prepare for the Urinary System Pathologies Test with comprehensive quizzes. Master key concepts through flashcards and multiple-choice questions. Boost your confidence and be exam-ready!

Multiple Choice

What is the effect of ACE inhibitors or ARBs on diabetic nephropathy?

Explanation:
The main idea is that diabetic nephropathy is driven by high pressure inside the glomeruli (intraglomerular pressure) that pushes albumin into the urine and accelerates kidney damage. ACE inhibitors and ARBs counter this by blocking the effects of angiotensin II, which normally constricts the efferent arteriole. With these drugs, the efferent arteriole dilates, lowering intraglomerular pressure. That drop in pressure reduces protein leakage (proteinuria) and slows the decline in kidney function, slowing progression of the disease. They can also lower systemic blood pressure, which helps, but the crucial renal effect is the reduction of intraglomerular pressure and proteinuria.

The main idea is that diabetic nephropathy is driven by high pressure inside the glomeruli (intraglomerular pressure) that pushes albumin into the urine and accelerates kidney damage. ACE inhibitors and ARBs counter this by blocking the effects of angiotensin II, which normally constricts the efferent arteriole. With these drugs, the efferent arteriole dilates, lowering intraglomerular pressure. That drop in pressure reduces protein leakage (proteinuria) and slows the decline in kidney function, slowing progression of the disease. They can also lower systemic blood pressure, which helps, but the crucial renal effect is the reduction of intraglomerular pressure and proteinuria.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy